# Optimal Morphine Dosing Schedule for Neonatal Abstinence Syndrome

> **NCT04298853** · PHASE4 · COMPLETED · sponsor: **Indiana University** · enrollment: 17 (actual)

## Conditions studied

- Neonatal Abstinence Syndrome
- Neonatal Opioid Withdrawal
- Neonatal Opioid Withdrawal Syndrome

## Interventions

- **DRUG:** Morphine PRN
- **DRUG:** Morphine scheduled

## Key facts

- **NCT ID:** NCT04298853
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-30
- **Primary completion:** 2021-10-01
- **Final completion:** 2021-10-01
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2022-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04298853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04298853, "Optimal Morphine Dosing Schedule for Neonatal Abstinence Syndrome". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04298853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*